Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-Human/Canine HER2 (domain III) Antibody (H2Mab-19)
Copy Product Info
🥰Excellent
Synonyms:
Catalog No. T9901A-2405 Copy Product Info
🥰Excellent
Anti-Human/Canine HER2 (domain III) Antibody (H2Mab-19) is an antibody targeting Human/Canine HER2 and can be used for oncology research.
Anti-Human/Canine HER2
(domain III) Antibody
(H2Mab-19)
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $158 | 6-8 weeks | 6-8 weeks | |
| 2 mg | $263 | 6-8 weeks | 6-8 weeks | |
| 5 mg | $518 | 6-8 weeks | 6-8 weeks | |
| 10 mg | $838 | 6-8 weeks | 6-8 weeks |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Antibody Information
Storage & Solubility Information
| Description | Anti-Human/Canine HER2 (domain III) Antibody (H2Mab-19) is an antibody targeting Human/Canine HER2 and can be used for oncology research. |
| Clone | H2Mab-19 |
| Reactivity | Human/Canine |
| Application | Functional assay |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | HER2/ERBB2 |
| Isotype | Mouse IgG2b kappa |
| Storage | -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags:
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.